I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Ensartinib is effective in the treatment of advanced non-sm..:
Yang, Yanping
;
He, Xincheng
;
Xiao, Wenxuan
..
Anti-Cancer Drugs. 35 (2023) 3 - p. 292-297 , 2023
Link:
https://doi.org/10.1097/cad.0000000000001559
RT Journal T1
Ensartinib is effective in the treatment of advanced non-small-cell lung cancer with MET amplification after multi-line ALK-TKIs resistance: a case report
UL https://suche.suub.uni-bremen.de/peid=cr-10.1097_cad.0000000000001559&Exemplar=1&LAN=DE A1 Yang, Yanping A1 He, Xincheng A1 Xiao, Wenxuan A1 Bai, Jun A1 Liu, Yi PB Ovid Technologies (Wolters Kluwer Health) YR 2023 SN 0959-4973 JF Anti-Cancer Drugs VO 35 IS 3 SP 292 OP 297 LK http://dx.doi.org/https://doi.org/10.1097/cad.0000000000001559 DO https://doi.org/10.1097/cad.0000000000001559 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)